Clinical Trial Update: Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

View source ↗

Summary

This clinical trial update reports on management strategies for major bleeding events in atrial fibrillation patients taking Pradaxa (dabigatran).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation, Hemorrhage | Status: COMPLETED | Results posted: 2016-04-04